Put the New Rivaroxaban VTE Prophylaxis Indication in Perspective

December 2019

A new rivaroxaban (Xarelto) indication will raise questions about inpatient and extended venous thromboembolism (VTE) prophylaxis.

You'll hear reps promote rivaroxaban 10 mg/day for VTE prophylaxis in MEDICAL inpatients...AND after discharge for up to 39 days total.

But point out the limitations with this new indication.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote